Billionaires are backing scientists in a race to develop tech that could reverse aging. How does cellular reprogramming work, ...

Discover the revival of the biotech sector, with IPOs resurging and promising weight loss drug potential, despite facing ...

Let's dive into a conversation with Ayla Ellison, Fierce Biotech Editor-in-Chief and Michelle ... We hope you can all join us on September 30th and October 1st in Boston. We hope to see you ...

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning. It’s another ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

September saw several notable 'firsts' in the regulatory landscape alongside the approval of four novel drugs in the U.S. Among ...

SALEM, MA, - Rob… An online-only webinar (by Invitation only) for US Corporate execs (CFOs ... a year long… Boston biotech increases target for pending IPO ...

A public offering of shares prompted a huge insider purchase last week. A couple of repeat buyers further boosted their ...

Ginkgo Bioworks is pivoting: Once a synthetic biology darling, the flailing company has now turned to AI-driven protein ...

US BIOTECH company Thermo Fisher Scientific, Inc. said it is expanding its Philippine workforce to staff a new Quezon City facility. “Our new global business services center will enhance and expand ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Samsung Biologics' share price closed at 1,087,000 won ($811.98), up 2.55 percent from the previous trading day, on the Kospi bourse on Monday. It marked another 52-week record after Samsung Biologics ...